Abstract:The aims of tuberculosis therapy are to cure the patient and to reduce the transmission of its etiologic agent, Mycobacterium tuberculosis , to both immunosuppressed and immunocompetent people. Although the expected rate of cure of antituberculosis treatment based on laboratory results is remarkably high, this efficacy does not always translate to effectiveness. The effectiveness of tuberculosis treatment corresponds to the successful outcome (cure) under operational conditions. Unsuccessful tuberculosis outcomes (death, loss to follow-up, or treatment failure) are associated with different variables, such as patient-related factors (age, comorbidities, individual vulnerability to toxicities, immune status, nutritional status, alcohol intake, adherence to treatment, drug tolerance, and genetic characteristics), organism/disease presentation-related factors (virulence of the organism, radiological extent of the disease, and susceptibility of the strain), care-related factors (motivational capacity of the staff, access of patients to the health care system, and monitoring and supervision of patients regarding treatment), and treatment-related factors (amount of each drug administered, plasma concentrations of administered drugs, relationship between administered drugs and proteins, clearance, metabolism, and absorption; drug bioavailability of the presentations, drug interactions with other drugs, treatment regimen, bactericidal and sterilizing potency, and drug synergy or antagonism). 1 1 Rabahi MF, Silva Júnior JLRD, Ferreira ACG, Tannus-Silva DGS, Conde MB. Tuberculosis treatment [published correction appears in J Bras Pneumol. 2018 Jul-Sep;44(4):340]. J Bras Pneumol. 2017;43(6):472-486. https://doi.org/10.1590/S1806-37562016000000388 https://doi.org/10.1590/S1806-3756201600... A study analyzing the temporal trend of tuberculosis cure indicators in Brazil is presented in this issue of the Jornal Brasileiro de Pneumologia . 2 2 Pavinati G, Lima LV, Bernardo PHP, Dias JR, Reis-Santos B, Magnabosco GT. A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022. J Bras Pneumol. 2024;50(2):e20240018. Pavinati et al. 2 2 Pavinati G, Lima LV, Bernardo PHP, Dias JR, Reis-Santos B, Magnabosco GT. A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022. J Bras Pneumol. 2024;50(2):e20240018. conducted an ecological time-series study using administrative data of reported cases of tuberculosis nationwide from 2001 to 2022. The authors of the study showed a decreasing trend toward cure indicators for new cases of pulmonary tuberculosis, cases of tuberculosis-HIV coinfection, and cases of retreatment, although results were heterogenous among the Brazilian Federative Units. The influence of the COVID-19 pandemic on the outcomes of this analysis is unmistakable. Nevertheless, a discernible trend was noticed across the three groups studied. Although a first increase in the percentages of cure was noted during the first temporal segment of the investigation, this was followed by a reversal of that trend in the later intervals, characterized by a decrease in cure rates. This observation became more marked in the final segment. These findings suggest that independent of the COVID-19 pandemic, other factors were already at play, contributing to the diminishing rates of tuberculosis cure in Brazil. These findings go in the opposite direction to the global average data. 3 3 World Health Organization (WHO). Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO. According to the WHO report 2023, there is an increasing trend toward the cure indicator worldwide among people newly diagnosed with tuberculosis and enrolled on first-line treatment, with a success rate of 88% for those enrolled in 2021. 3 3 World Health Organization (WHO). Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO. Data from a very recent epidemiological report of the Ministry of Health of Brazil showed a decrease in the cure rate of sensitive cases of tuberculosis (from 76.5% in 2013 to 73.8% in 2019). 4 4 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Boletim Epidemiológico. Tubercul -Abstract Truncated-

A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022

Decreasing trends in tuberculosis cure indicators in Brazil

Unsuccessful tuberculosis treatment outcomes across Brazil's geographical landscape before and during the COVID-19 pandemic: are we truly advancing toward the sustainable development/end TB goal?

Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data

Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil

IMPACT OF THE COVID-19 PANDEMIC ON TUBERCULOSIS CONTROL IN BAHIA

Epidemic Trends in High Tuberculosis Burden Countries During the Last Three Decades and Feasibility of Achieving the Global Targets at the Country Level

Retreatment and Antituberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study

Time until tuberculosis recurrence and associated factors in Brazil: a populationbased retrospective cohort study using a linked database

Impact of the improvement of living conditions on tuberculosis mortality in Brazil: an ecological study

Crucial Actions for Intensifying Efforts

Temporal Pattern and Spatial Distribution of Tuberculosis Prevalence Associated with Multimorbidity in Brazil

Prevalence and Spatial Autocorrelation of Tuberculosis in Indigenous People in Brazil, 2002-2022

Factors associated with unsuccessful tuberculosis treatment in Manaus, Amazonas, from 2011 to 2021

Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010-15: a population-based, longitudinal study

[Tuberculosis in the Brazilian prison system: scenarios via Joinpoint, from 2007 to 2019]

Mitigating adverse outcomes in tuberculosis treatment: analyzing a non-compliance risk assessment strategy in a case report

Predictors of unsuccessful tuberculosis treatment outcomes in Brazil: an analysis of 259,484 patient records

Epidemic Trends of Tuberculosis in China from 1990 to 2017: Evidence from the Global Burden of Disease Study.

Time Trends in Tuberculosis Mortality Across the BRICS: an Age-Period-cohort Analysis for the GBD 2019

Impact of Xpert MTB/RIF implementation in tuberculosis case detection and control in Brazil: a nationwide intervention time-series analysis (2011-2022)